Ameritas Investment Partners’s Kindred Biosciences, Inc. KIN Stock Holding History

Ameritas Investment Partners’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,315	Closed	-$16K	–	3338
2021 Q1	$16K	Hold	3,315	–	–	﹤0.01%	2666
2020 Q4	$14K	Hold	3,315	–	–	﹤0.01%	2666
2020 Q3	$14K	Hold	3,315	–	–	﹤0.01%	2578
2020 Q2	$15K	Hold	3,315	–	–	﹤0.01%	2527
2020 Q1	$13K	Buy	3,315 +747	+29%	+$6.34K	﹤0.01%	2424
2019 Q4	$22K	Hold	2,568	–	–	﹤0.01%	2379
2019 Q3	$18K	Hold	2,568	–	–	﹤0.01%	2457
2019 Q2	$21K	Hold	2,568	–	–	﹤0.01%	2426
2019 Q1	$24K	Hold	2,568	–	–	﹤0.01%	2298
2018 Q4	$28K	Buy	2,568 +720	+39%	+$9.07K	﹤0.01%	2153
2018 Q3	$26K	Hold	1,848	–	–	﹤0.01%	2383
2018 Q2	$20K	Hold	1,848	–	–	﹤0.01%	2528
2018 Q1	$16K	Hold	1,848	–	–	﹤0.01%	2542
2017 Q4	$17K	Hold	1,848	–	–	﹤0.01%	2523
2017 Q3	$14K	Hold	1,848	–	–	﹤0.01%	2628
2017 Q2	$16K	Buy	+1,848	New	+$13.3K	﹤0.01%	2608

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Ameritas Investment Partners's KIN Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Kindred Biosciences, Inc. (KIN) in Q2 2021, closing a stake of 3,315 shares — an estimated $16K sold.

Ameritas Investment Partners first reported a position in KIN in Q2 2017 and held it in 16 quarters. The position peaked at $28K in Q4 2018. 87 funds tracked by Wall St. Rank hold KIN as of Q2 2021.

Ameritas Investment Partners reported no remaining Kindred Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 3,315 Kindred Biosciences, Inc. shares in Q2 2021, an estimated $16K.
Ameritas Investment Partners first reported a position in Kindred Biosciences, Inc. in Q2 2017 and held it in 16 quarters.
Ameritas Investment Partners's Kindred Biosciences, Inc. position peaked at $28K in Q4 2018.
87 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.